- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01290991
A Study to Evaluate the Safety of Augment™ Bone Graft
20. august 2012 opdateret af: William Stanish, Nova Scotia Health Authority
A Pilot Study to Augment™ Bone Graft Plus Evaluate the Safety of Allograft for Treatment of Osteochondral Defects (OCD) of the Knee
Is Augment Bone Graft plus Allograft safe to use for the treatment of osteochondral defects of the knee?
Studieoversigt
Detaljeret beskrivelse
Subjects will be 18 to 40 years with an osteochondral defects of the knee.They will be candidates for allograft and Augment Bone Graft will be added to the procedure.
The safety of Augment Bone Graft plus allograft for osteochondral defects of the knee will be evaluated by type, frequency, severity and relatedness of adverse events to the device for a minimum of 24 weeks.Magnetic Resonance Imaging will be performed at 1,12 and 42 weeks to evaluate device integrity and surgical treatment of osteochondral defects.
Computed tomography will be done at week 1 and week 24 to determine the healing status of the osteochondral defect.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
1
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 3A7
- Queen Elizabeth ll Health Sciences Centre
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 40 år (Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Prior Magnetic Resonance Imaging (MRI) evaluation or MRI on Screening.
- Subjects with Grade III osteochondral defect (OCD) of femoral condyle.
- Subjects with OCD > 1 cm.squared.
- Independent and ambulatory pts.
- Subjects from 18 to 40 years of age.
- Subject with a stable knee joint and similar stability on the opposite knee.
- Subject has knee x-ray with < 15 degrees of valgus and < 5 degrees varus.
- No deformity from previous fractures of tibia or fibula.
- BMI < 35.
- Subject has an American Association of Anaesthetists physical status classification of 1 or 2.
- Subject must present with pain > 3.0 cm according to the Visual Analogue Score.
- Subject has exhausted non operative treatment.
Exclusion:
- Allergy to yeast derived products.
- Index knee has had cartilage repair in the last six months.
- Subjects with osteoarthritis,inflammatory arthritis, rheumatoid arthritis and avascular necrosis of index knee.
- Subject has contralateral knee complications which would interfere with rehabilitation
- Subject has implanted metallic devices that would prevent Magnetic Resonance Imaging (MRI).
- Subject has claustrophobia that would prevent MRI.
- Subject has had a malignancy or is being treated for a malignancy.
- Subject is physically or mentally compromised that would interfere with compliance.
- Subject is a prisoner or transient.
- Subject has a recent history (12 months) of alcohol abuse.
- Subject is pregnant, able to become pregnant but not practising birth control.
- Subject has an infection in the operative area.
- Subject has scheduled surgery on the contralateral knee over the course of the study.
- Subject requires another procedure in the index knee.
- Subject has had steroid therapy in the past six months.
- Subject is taking prescription pain medication for another indication other than the index knee.
- Subject is using nicotine in any form.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Bone Graft
Single Arm.. Augment Bone Graft for Osteochondral Defects
|
Augment Bone Graft physically fills bone defects by providing a biocompatible scaffold for new bone formation.The material is comprised of a matrix of beta tricalcium phosphate and a highly purified recombinant human platelet-derived growth factor.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
To evaluate the safety of Augment Bone Graft plus Allograft for treatment of osteochondral defects of the knee.
Tidsramme: 12 months
|
Collection of related adverse events
|
12 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
To utilize Magnetic Resonance Imaging to evaluate device integrity and surgical treatment of osteochondral defects of the knee.
Tidsramme: 12 months
|
Assess healing and bone formation from radiological reports
|
12 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: William D Stanish, MD, Capital Dictrict Health Authority
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. juli 2011
Primær færdiggørelse (Faktiske)
1. august 2012
Studieafslutning (Faktiske)
1. august 2012
Datoer for studieregistrering
Først indsendt
2. februar 2011
Først indsendt, der opfyldte QC-kriterier
4. februar 2011
Først opslået (Skøn)
7. februar 2011
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
21. august 2012
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
20. august 2012
Sidst verificeret
1. august 2012
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Stanish-2010-01
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Augment Bone Graft
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)AfsluttetDepressionForenede Stater
-
Children's Hospital Los AngelesRekrutteringCerebral Parese | Pædiatrisk ALT | Fysisk handicap | Brug af mobiltelefon | Fysisk inaktivitetForenede Stater
-
BioMimetic TherapeuticsAfsluttetFod FusionForenede Stater, Canada
-
BioMimetic TherapeuticsUkendtAnkel- og bagfodsartrodeseForenede Stater, Canada
-
BioMimetic TherapeuticsUkendt
-
Assistance Publique - Hôpitaux de ParisAfsluttetSkallefiksering efter kraniotomi til neurokirurgiske indgrebFrankrig
-
BioMimetic TherapeuticsAfsluttetFuld tykkelse rotator manchet riveCanada
-
BioMimetic TherapeuticsAfsluttetGigt | Slidgigt | Rheumatoid arthritis | Degenerativ ledsygdom | Medfødt deformitetForenede Stater, Canada
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulAfsluttetUrethral Forsnævring
-
Johns Hopkins UniversityAfsluttetSlutstadie nyresygdom | Hæmolyse | Arteriovenøs graftForenede Stater